WO2002098296A1 - Pressure sensing endograft - Google Patents
Pressure sensing endograft Download PDFInfo
- Publication number
- WO2002098296A1 WO2002098296A1 PCT/US2002/017062 US0217062W WO02098296A1 WO 2002098296 A1 WO2002098296 A1 WO 2002098296A1 US 0217062 W US0217062 W US 0217062W WO 02098296 A1 WO02098296 A1 WO 02098296A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- endograft
- pressure
- sleeve
- pressure sensor
- diaphragm
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6867—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
- A61B5/6876—Blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/02007—Evaluating blood vessel condition, e.g. elasticity, compliance
- A61B5/02014—Determining aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/076—Permanent implantations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6862—Stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0214—Operational features of power management of power generation or supply
- A61B2560/0219—Operational features of power management of power generation or supply of externally powered implanted units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0001—Means for transferring electromagnetic energy to implants
- A61F2250/0002—Means for transferring electromagnetic energy to implants for data transfer
Definitions
- the present invention relates generally to endovascular implants, and, more specifically, to their construction, use, and monitoring.
- a common procedure for the treatment of aneurysms is the use of endovascular implants or grafts, referred to herein as endografts.
- endografts endovascular implants or grafts, referred to herein as endografts.
- a collapsed endograft is guided to the site of the aneurysm with an arterial catheter.
- the endograft is positioned to span the aneurysm sac and expanded so that the ends of the endograft form a seal with the aorta upstream and downstream of the aneurysm.
- the arterial pressure is then borne by the endograft, and the pressure within the aneurysm is relieved.
- a common complication of this procedure is endoleakage.
- Endoleakage is leakage around the ends of the endograft. Endoleakage occurs when the ends of the endograft do not completely seal with the aortic wall. Another common complication is retrograde flow into the aneurysm sac through collateral arteries. Both these conditions can lead to repressurization and possible rupture of the aneurysm sac. These conditions generally can be detected with CT scans. However, the failure to visualize endoleaks does not preclude their presence. Furthermore, the possibility of endoleaks is open-ended, so that all patients with AAA endografts should be followed for life with CT scans. The current monitoring procedures using CT scans give limited data at infrequent intervals and at high cost. Accordingly, an improved endovascular implant is desired for reducing cost and improving use thereof.
- An endovascular implant or endograft includes a tubular sleeve having integral inner and outer layers.
- a pressure sensor is embedded between the two layers and is covered thereby.
- the sleeve is flexible at the pressure sensor to permit transfer of pressure through the sleeve for detection by the pressure sensor in use.
- Figure 1 is a schematic view of an endograft implanted in the aorta of a living patient to repair or bridge an aneurysm in accordance with an exemplary embodiment of the present invention.
- Figure 2 is an enlarged partly sectional view of a portion of the endograft illustrated in Figure 1 showing an exemplary pressure sensor embedded therein.
- Figure 3 is a radial cross sectional view through the middle of the endograft illustrated in Figure 1 within the aneurysm showing two exemplary pressure sensors embedded therein for measuring external and internal pressure of the endograft.
- Figure 4 is a radial sectional view through one end of the endograft implanted in the aorta illustrated in Figure 1 showing three exemplary pressure sensors embedded therein.
- Figure 5 is an enlarged sectional view of one of the embedded pressure sensors illustrated in Figure 4.
- Figure 6 is a schematic view for implanting the endograft illustrated in Figure 1 using a balloon catheter.
- Figure 7 is a isometric view of an exemplary stent usable with the endograft illustrated in Figure 1 and modified to include an additional pressure sensor integrated therewith in accordance with another embodiment of the present invention.
- Figure 8 is an enlarged view of a portion of the stent illustrated in Figure 7 showing the pressure sensor fixedly joined therein in accordance with an exemplary embodiment.
- Figure 9 is an enlarged view of the stent illustrated in Figure 7 showing a box frame for trapping the pressure sensor in the stent in accordance with another embodiment of the present invention.
- Figure 10 is a flowchart representation of analysis of selective pressures monitored in the endograft illustrated in Figure 1 for detecting leakage around the endograft during use.
- Figure 1 1 is an equivalent electrical circuit representative of leakage around the endograft illustrated in Figure 1 .
- Illustrated schematically in Figure 1 is an exemplary body vessel or lumen 10 found under the skin 1 2 inside the body of a living human patient.
- the vessel 10 may be the aorta of the heart and carries a body fluid or liquid 14 such as blood flow.
- the vessel 10 includes an aneurysm 16 in the form of an enlarged sac in which the normally tubular vessel has a locally enlarged weak portion.
- the aneurysm is repaired by the introduction of an artificial endovascular implant or endograft 18 implanted inside the vessel to bridge the aneurysm and return this region of the vessel to the normal tubular shape.
- Figure 2 illustrates an enlarged portion of the endograft illustrated in Figure 1 which is in the preferred form of a two-ply tubular sleeve defined by integral inner and outer plies or layers 20,22.
- the sleeve layers 20,22 are in the form of a woven fabric of Dacron, for example. Any conventional material may be used for the endograft.
- the endograft is provided with the two plies for integrating therein one or more pressure sensors S1 , S2, and S3, for example. Each pressure sensor is self-contained and sufficiently small in size and configuration for being embedded or trapped wholly between the inner and outer layers and completely covered thereby.
- the inner and outer layers 20,22 are coextensive between opposite ends of the sleeve, with each layer being tubular and concentric with the opposite layer.
- the two layers may be interwoven during manufacture or may be separately produced and joined together by suitable stitching.
- each of the pressure sensors such as S2
- each pressure sensor is embedded between the two plies and may be locally captured therein by surrounding stitching 24. In this way, each pressure sensor is trapped in the endograft itself and cannot be liberated inside the patient during use.
- the endograft sleeve could be a single ply woven fabric, for example, with small fabric patches sewn over each of the pressure sensors for embedding them in the endograft.
- Such fabric patches may be located either inside or outside the endograft sleeve.
- the fabric material of the endograft sleeve is preferably flexible at each of the pressure sensors to conform the shape of the sleeve to the pressure sensor and to permit transfer of pressure through the sleeve to the pressure sensor for accurate pressure sensing capability.
- the several pressure sensors illustrated in Figure 1 are preferably identical to each other, and Figure 2 illustrates an exemplary configuration thereof.
- Each pressure sensor preferably includes a flat pressure sensing surface or diaphragm 26, and the fabric sleeve is at least locally flexible in the vicinity of each pressure sensor to conform flat with the flat diaphragm.
- Each pressure sensor S1 -3 may have any conventional form with its size being preferably a small as possible.
- a preferred form of a solid-state transducer pressure sensor for use in the endograft 1 8 is disclosed in an article entitled "A Wireless Batch Sealed Absolute Capacitive Pressure Sensor," by Akar, et al., as published beginning at page 585 of Eurosensors XIV, the 14th European Conference on solid-state transducers, August 27-30, 2000, Copenhagen, Denmark.
- a suitable telemetry device 28 includes an electrically powered external coil or inductor in a circuit with another resistor which can be used for inductively coupling each of the pressure sensors with the telemetry device 28 for detecting pressure sensed by the pressure sensor.
- the endograft and its integrated pressure sensors S1 -3 may be implanted inside the patient, with the pressure being detected externally of the patient by the remote telemetry device 28 located outside the skin 12.
- the endograft 1 8 is used in a system for monitoring pressures related to the performance of the implanted endograft itself, and for monitoring arterial pressure in the blood vessel.
- one or more pressure sensors S1 are embedded in the endograft 18 so that endograft material totally surrounds the sensors, with their pressure-sensing surfaces facing outward toward the aneurysm sac.
- one or more pressure sensors S2 are embedded in the endograft 18 so that endograft material totally surrounds the sensors, with their pressure-sensing surfaces facing inward toward the inside of the lumen to measure the patient's blood pressure.
- one or more pressure sensors S3 are embedded near the ends of the endograft 18 so that endograft material totally surrounds the sensors, with their pressure-sensing surfaces facing outward toward the aortic wall. These sensors sense the clamping pressure caused by hoop stresses in the aortic wall that push the aortic wall against the sealing surface of the endograft under the action of the patient's blood pressure.
- the signals generated by the sensors S1 , S2, and S3 may be monitored, combined, and processed to provide pressure information to assist in the surgical installation of the endograft and also in monitoring the long-term performance of the endograft.
- the electromagnetic energy can be wirelessly passed through the wall of the artery to supply power to the pressure sensors, and return signals from the pressure sensors may be remotely detected.
- One advantage of the pressure-sensing endograft is that blood pressure within an aneurysm sac and the endograft lumen can be directly monitored.
- a further advantage of the endograft is that the number of costly CT scans for patients with endovascular grafts can be reduced.
- a further advantage of the endograft is that the blood pressure within an the aneurysm sac and within the endograft lumen can be periodically monitored using pressure differential trends for a more timely diagnosis of endoleakage.
- a further advantage of the endograft is that the clamping pressure between the endograft and aorta can be monitored during the insertion procedure to determine when a secure fit has been achieved.
- a further advantage of the endograft is that the frequency content and pulsatility of the dynamic pressure signals from the sensors measuring aneurysm sac pressure can be compared with the endograft luminal pressure to provide further indication of the performance of the endograft.
- the clamping pressure between the endograft and aorta can be monitored after the implantation procedure to monitor the integrity of the fit. Yet a further advantage is that these pressures can be monitored wirelessly, so that no wires need penetrate the skin or the artery, and the associated complications of infection and thrombus generation can be avoided.
- the pressure sensors S1 through S3 illustrated in figure 1 are preferably embedded inside the endograft material, e.g. woven or knitted synthetic fiber such as Dacron, so that endograft material totally surrounds the sensor beneath a flattened portion to form a flat pressure-sensing surface. The endograft material smoothly blends back to the otherwise curved portion of the endograft.
- first and second pressure sensors S1 and S2 are preferably located centrally in the middle of the endograft generally equally between the opposite ends of the sleeve.
- the flat diaphragm 26 of the first pressure sensor S1 faces radially outwardly and contacts the outer sleeve layer 22 as illustrated in Figure 3 for sensing external pressure Ps outside the endograft sleeve and within the aneurysm sac 16.
- the first pressure sensor S1 is therefore oriented for measuring pressure in the aneurysm sac 1 6. Multiple sensors S1 may be used for redundancy.
- the pressure-sensing surface 26 of sensor S1 faces outwardly toward the aneurysm sac.
- the pressure inside the aneurysm sac is communicated to the pressure sensor through the flattened endograft wall.
- the second pressure sensor S2 illustrated in Figures 1 and 3 has its flat diaphragm 26 facing radially inward and contacts the inner layer 20 of the endograft sleeve for sensing internal pressure Pa inside the endograft.
- the second pressure sensor S2 is preferably located centrally between the opposite ends of the endograft in the same plane as the first pressure sensor S1 , but may be located at any axial location along the endograft where it measures the internal pressure of the flood flow therein.
- the second pressure sensor S2 is therefore oriented for measuring pressure inside the endograft, which corresponds to the local vascular pressure within the lumen of the endograft. Multiple sensors S2 may be used for redundancy and to detect high flow resistances in the endograft.
- the pressure-sensing surface 26 of sensor S2 faces inwardly toward the interior of the endograft.
- the outer layer 22 of endograft material pushes the pressure sensor inward sufficiently to flatten the inner layer 20 of the endograft material against the pressure-sensing surface.
- the pressure inside the endograft is communicated to the pressure sensor through this flattened endograft wall.
- each end of the endograft includes three equiangularly spaced apart third pressure sensors S3 at a 120° spacing.
- the end sensors S3 face radially outwardly as illustrated in Figures 4, 5, and 6 to measure contact or clamping pressure Pc exerted against the endograft after it is expanded against the inner wall of the vessel 10.
- the third pressure sensors S3 are therefore provided for measuring the clamping pressure between the endograft and the aortic wall.
- the sensors S3 are outward facing and positioned adjacent to each end of the endograft where the endograft engages with the aortic wall. Multiple sensors S3 are preferably used at each end for redundancy, and to detect circumferential variations in the clamping pressure. An endograft that is properly engaged with an aortic wall will expand the aortic wall elastically. A circumferential hoop stress will be established in the aortic wall that will tend to cause an even clamping pressure to be detected by the sensors S3.
- the endograft includes all three types of pressure sensors S1 , S2, and S3.
- the first pressure sensor S1 has its diaphragm 26 facing outwardly for detecting pressure Ps in the aneurysm sac 16.
- the second pressure sensor S2 has its diaphragm facing radially inwardly for detecting pressure Pa inside the endograft lumen.
- the third pressure sensors S3 are arranged in groups of three at opposite ends of the endograft with their diaphragms 26 facing radially outwardly for detecting the clamping pressure Pc.
- Figure 2 shows the pressure sensor mounted integral within layers of endograft material.
- the layers of endograft material surround the pressure sensor to prevent detachment.
- the endograft material is typically a woven fabric.
- the weave of the endograft material should be sufficiently fine that the pores are substantially smaller than the pressure sensor notwithstanding any stretching or flexing of the endograft. This configuration minimizes the possibility of the sensor passing through a pore or otherwise becoming detached from the endograft.
- the implanted endograft material produces a smooth, biocompatible tissue-incorporation that becomes an integral part of the sensor diaphragm.
- the pressure sensor diaphragm such as silicon, is made to be stiffer than any tissue that may build up on its surface.
- the endograft also includes an expandable stent 32 disposed coaxially with the two- ply sleeve thereof for structurally supporting the endograft when implanted in the blood vessel.
- the stent preferably surrounds the endograft sleeve and may be sewn to the fabric thereof.
- the inside of the endograft sleeve remains smooth for maintaining a substantially smooth continuous flowpath for the blood flowing therethrough during operation.
- the stent generally has a single layer of expandable meshwork that undergoes plastic deformation to expand to form a rigid scaffolding to hold open the endograft in an artery.
- the stent is typically made of a biocompatible metal, such as Nitinol, stainless steel, or titanium. Illustrated in Figures 7 and 8 is the stent 32 of the endograft illustrated in Figure 1 removed therefrom which may include another or fourth pressure sensor S4 fixedly joined to the stent.
- the stent includes a mesh or grid of interconnected wires 34, and the stent pressure sensor S4 is locally joined to at least one of the wires for retention thereto.
- the diaphragm 26 of the fourth pressure sensor S4 may face outwardly or inwardly as desired.
- a plurality of the mesh wires 34 are cut and bent to mechanically trap the pressure sensor to the adjoining mesh wires.
- the bent mesh wires preferably trap the perimeter of the pressure sensor without covering the diaphragm 26 or preventing pressure sensing operation thereof. Since the pressure sensor is supported by the cut mesh wires, it is freely carried along with the underlying uncut wires as the stent mesh is expanded in use to increase the cylindrical diameter of the tubular stent from its initially small- diameter collapsed form. The stent may therefore freely expand without local distortion around the retained pressure sensor.
- Figure 9 illustrates an alternate embodiment of the stent 32 in which the mesh wires 34 are not cut but define suitably sized openings or cells between the wires in which the pressure sensor may be mounted.
- a perforate frame or box 36 is fixedly joined to one or more of the mesh wires by a weld joint 38.
- the box may have six sides and a closure flap which is initially open for permitting the pressure sensor S4 to be inserted therein during assembly. The flap may then be simply bent closed for retaining the pressure sensor in the box.
- the box preferably has two large windows on opposite sides thereof for permitting unobstructed access of the blood to the sensing diaphragm 26. Since the box is secured in one of the mesh cells, the stent may be readily expanded during implantation without restraint by the mounting box itself.
- the endograft illustrated in the preferred embodiment in Figure 1 incorporates integral pressure sensing capability which may be used to advantage during its initial implantation in the patient as well as for subsequent monitoring of endograft performance thereafter.
- the endograft may be used for detecting leakage around the endograft after its implantation.
- the implanted endograft bridges the aneurysm sac 16, with opposite ends of the endograft contacting inner surfaces of the aorta 10 at opposite ends of the aneurysm to provide effective seals thereat and channel blood through the endograft instead of the aneurysm.
- the first pressure sensor S1 may then be used to detect external pressure outside the implanted endograft and inside the aneurysm sac for detecting pressure of any blood leakage therein.
- the second pressure sensor S2 may be correspondingly used to detect internal pressure inside the endograft due to the pressure of the blood 14 channeled therethrough. By simply comparing the external and internal pressures detected by the first and second pressure sensors, an indication of endoleakage may be derived.
- the external pressure of the endograft should be substantially lower than the internal pressure for normal, sealed operation of the opposite endograft ends.
- Figure 6 illustrates an exemplary method of using or implanting the endograft 18.
- the endograft 18 in initially collapsed form is mounted around a conventional balloon catheter 40 and conventionally guided through a suitable artery to a desired position inside the aorta 14 to internally bridge the aneurysm sac 16.
- the balloon catheter may then be expanded for in turn expanding the endograft and its supporting stent into engagement with the inner surface of the aorta.
- the two groups of third pressure sensors S3 may then be used for monitoring the clamping pressure of engagement of the endograft with the aorta wall at opposite ends of the endograft sleeve. Endograft expansion by the balloon catheter may be terminated upon reaching a suitable value of monitored clamping pressure as detected by the third pressure sensors.
- the sensors are embedded in the endograft, separate surgical procedures for implantation thereof are not necessary. Furthermore, because the embedded pressure sensors are read by telemetry, no separate surgical procedure is required for monitoring the pressures needed to diagnose the pressure integrity of the endograft. Thus, follow-up diagnostics for pressure integrity using these sensors are a non-invasive procedure.
- the patient's blood pressure may vary considerably from moment to moment. These pressure variations may or may not be related to the integrity of the endograft or any leakage of blood into the abdomen. These blood pressure variations may result in artifacts generated in the pressure of the aneurysm sac. Thus, to reduce these artifacts, the differential pressures between the endograft luminal pressure and the aneurysm sac pressure may be monitored.
- Pa aortic pressure in the endograft lumen 18
- Ma mean pressure in the endograft lumen
- Ppa pulsatile pressure in the endograft lumen
- Pa Ma + Ppa
- Ps pressure in the aneurysm sac
- Ms mean pressure in the aneurysm sac
- Pps pulsatile pressure in the aneurysm sac
- Ps Ms + Pps
- Mean difference Ma - Ms
- the mean difference may be zero, but there can be an immediate and significant pulsatile difference as soon as the aneurysm is isolated. Over time, the mean difference should increase as the blood in the aneurysm sac transforms into a shrunken thrombus.
- the amount of endoleak can be inferred from the following approach.
- An analysis of the attenuation of the frequency content of pressure signals reported by S1 and S2 can be an indicator of the impedance of the leak path and the degree to which a high resistance, tight seal has been achieved. This impedance can be analyzed using techniques well known in the art of circuit design.
- a resistor-capacitor circuit models the performance of the pressure sensing system.
- R the resistance to flow from the artery to the aneurysm sac
- C the capacity of the aneurysm sac
- Pps the pulsatile pressure in the aneurysm sac reported by sensor S1 , and corresponds to the voltage V1 in an equivalent electrical circuit
- Ppa the pulsatile pressure in the artery reported by sensor S2
- the period of the frequency component is small compared to the characteristic time T, i.e., a high frequency component, a small fraction of the pulsatile arterial pressure Ppa is transmitted to the aneurysm sac as Pps.
- the period of the frequency component is large compared to the characteristic time T, i.e., a low frequency component, most of pulsatile arterial pressure Ppa is transmitted to the aneurysm sac as Pps.
- the cutoff frequency of this low-pass filter (1 /RC) can be used to infer the value of the resistance R with respect to the capacity C.
- R becomes the resistance to flow, in the form of Pressure/Flow through the leak, in units of mmHg/(cc/sec).
- the capacitance C becomes the compliance of the aneurysm sac, in units of cc/mmHg.
- the capacitance C is related to the size of the aneurysm sac, which can be seen through radiological images.
- a typical compliance for an expanded aneurysm sac can be in the range of 1 cc/mmHg.
- the mean components of the external pressure Ps(t) and internal pressure Pa(t) may be compared, in a suitable signal processor for example, for detecting endoleakage.
- a conventional frequency analyzer may be used to uncover the frequency spectra of the pulsatile components of the external and internal pressures as distinct from the mean components thereof for detecting endoleakage. For example, attenuation of the pulsatile components and cutoff frequency therefrom may be determined for detecting the endoleakage in the form of the RC leakage rate described above.
- one way to prevent the progression of further aneurysms is to monitor for hypertension, treat the hypertension with appropriate drugs, and monitor for drug effectiveness and patient compliance.
- the ability for the patient ambulatory monitoring of his/her blood pressure may be a valuable clinical tool.
- the pressure sensing endograft described above integrates minute pressure sensors therein for improving both performance of the initial implantation thereof, as well as monitoring use of the endograft over time. Telemetry reading of embedded pressure sensors eliminates need for any surgical procedures in monitoring endograft performance. And, continual monitoring of endograft performance ensures its effectiveness in preventing leakage into the aneurysm.
Abstract
An endovascular implant or endograft (18) includes a tubular sleeve having integral inner and outer layers (20, 22). A pressure sensor (S1-3) is embedded between the two layers and is covered thereby. And, the sleeve is flexible at the pressure sensor to permit transfer of pressure through the sleeve for detection by the pressure sensor in use.
Description
PRESSURE SENSING ENDOGRAFT
TECHNICAL FIELD
The present invention relates generally to endovascular implants, and, more specifically, to their construction, use, and monitoring.
BACKGROUND ART
A common procedure for the treatment of aneurysms, for example, abdominal aortic aneurysms (AAAs), is the use of endovascular implants or grafts, referred to herein as endografts. In this procedure, a collapsed endograft is guided to the site of the aneurysm with an arterial catheter. The endograft is positioned to span the aneurysm sac and expanded so that the ends of the endograft form a seal with the aorta upstream and downstream of the aneurysm. The arterial pressure is then borne by the endograft, and the pressure within the aneurysm is relieved. A common complication of this procedure is endoleakage. Endoleakage is leakage around the ends of the endograft. Endoleakage occurs when the ends of the endograft do not completely seal with the aortic wall. Another common complication is retrograde flow into the aneurysm sac through collateral arteries. Both these conditions can lead to repressurization and possible rupture of the aneurysm sac. These conditions generally can be detected with CT scans. However, the failure to visualize endoleaks does not preclude their presence. Furthermore, the possibility of endoleaks is open-ended, so that all patients with AAA endografts should be followed for life with CT scans. The current monitoring procedures using CT scans give limited data at infrequent intervals and at high cost. Accordingly, an improved endovascular implant is desired for reducing cost and improving use thereof.
DISCLOSURE OF INVENTION
An endovascular implant or endograft includes a tubular sleeve having integral inner and outer layers. A pressure sensor is embedded between the two layers and is covered thereby. And, the sleeve is flexible at the pressure sensor to permit transfer of
pressure through the sleeve for detection by the pressure sensor in use.
BRIEF DESCRIPTION OF DRAWINGS
The invention, in accordance with preferred and exemplary embodiments, together with further objects and advantages thereof, is more particularly described in the following detailed description taken in conjunction with the accompanying drawings in which: Figure 1 is a schematic view of an endograft implanted in the aorta of a living patient to repair or bridge an aneurysm in accordance with an exemplary embodiment of the present invention. Figure 2 is an enlarged partly sectional view of a portion of the endograft illustrated in Figure 1 showing an exemplary pressure sensor embedded therein. Figure 3 is a radial cross sectional view through the middle of the endograft illustrated in Figure 1 within the aneurysm showing two exemplary pressure sensors embedded therein for measuring external and internal pressure of the endograft. Figure 4 is a radial sectional view through one end of the endograft implanted in the aorta illustrated in Figure 1 showing three exemplary pressure sensors embedded therein. Figure 5 is an enlarged sectional view of one of the embedded pressure sensors illustrated in Figure 4. Figure 6 is a schematic view for implanting the endograft illustrated in Figure 1 using a balloon catheter. Figure 7 is a isometric view of an exemplary stent usable with the endograft illustrated in Figure 1 and modified to include an additional pressure sensor integrated therewith in accordance with another embodiment of the present invention. Figure 8 is an enlarged view of a portion of the stent illustrated in Figure 7 showing the pressure sensor fixedly joined therein in accordance with an exemplary embodiment. Figure 9 is an enlarged view of the stent illustrated in Figure 7 showing a box frame for trapping the pressure sensor in the stent in accordance with another embodiment of the present invention. Figure 10 is a flowchart representation of analysis of selective pressures monitored in the endograft illustrated in Figure 1 for detecting leakage around the endograft during use. Figure 1 1 is an equivalent electrical circuit representative of leakage around the
endograft illustrated in Figure 1 .
MODE(S) FOR CARRYING OUT THE INVENTION
Illustrated schematically in Figure 1 is an exemplary body vessel or lumen 10 found under the skin 1 2 inside the body of a living human patient. For example, the vessel 10 may be the aorta of the heart and carries a body fluid or liquid 14 such as blood flow. In the exemplary embodiment illustrated in Figure 1 the vessel 10 includes an aneurysm 16 in the form of an enlarged sac in which the normally tubular vessel has a locally enlarged weak portion. The aneurysm is repaired by the introduction of an artificial endovascular implant or endograft 18 implanted inside the vessel to bridge the aneurysm and return this region of the vessel to the normal tubular shape. Figure 2 illustrates an enlarged portion of the endograft illustrated in Figure 1 which is in the preferred form of a two-ply tubular sleeve defined by integral inner and outer plies or layers 20,22. In the preferred embodiment, the sleeve layers 20,22 are in the form of a woven fabric of Dacron, for example. Any conventional material may be used for the endograft. In accordance with the present invention, the endograft is provided with the two plies for integrating therein one or more pressure sensors S1 , S2, and S3, for example. Each pressure sensor is self-contained and sufficiently small in size and configuration for being embedded or trapped wholly between the inner and outer layers and completely covered thereby. In the exemplary embodiment illustrated in Figures 1 and 2, the inner and outer layers 20,22 are coextensive between opposite ends of the sleeve, with each layer being tubular and concentric with the opposite layer. The two layers may be interwoven during manufacture or may be separately produced and joined together by suitable stitching. As shown in Figure 2, each of the pressure sensors, such as S2, is embedded between the two plies and may be locally captured therein by surrounding stitching 24. In this way, each pressure sensor is trapped in the endograft itself and cannot be liberated inside the patient during use. In alternate embodiments, the endograft sleeve could be a single ply woven fabric, for example, with small fabric patches sewn over each of the pressure sensors for embedding them in the endograft. Such fabric patches may be located either inside or outside the endograft sleeve. As initially illustrated in Figure 2, the fabric material of the endograft sleeve is
preferably flexible at each of the pressure sensors to conform the shape of the sleeve to the pressure sensor and to permit transfer of pressure through the sleeve to the pressure sensor for accurate pressure sensing capability. The several pressure sensors illustrated in Figure 1 are preferably identical to each other, and Figure 2 illustrates an exemplary configuration thereof. Each pressure sensor preferably includes a flat pressure sensing surface or diaphragm 26, and the fabric sleeve is at least locally flexible in the vicinity of each pressure sensor to conform flat with the flat diaphragm. In this way, the endograft sleeve will not obstruct proper operation of the miniature pressure sensors. Each pressure sensor S1 -3 may have any conventional form with its size being preferably a small as possible. For- example, a preferred form of a solid-state transducer pressure sensor for use in the endograft 1 8 is disclosed in an article entitled "A Wireless Batch Sealed Absolute Capacitive Pressure Sensor," by Akar, et al., as published beginning at page 585 of Eurosensors XIV, the 14th European Conference on solid-state transducers, August 27-30, 2000, Copenhagen, Denmark. Particular advantage of these solid-state transducers is their minute size, telemetric capability, and small silicon diaphragms which form one plate of a capacitor used for accurately measuring pressure thereagainst. The silicon diaphragm 26 is illustrated in Figure 2 along with a schematic representation of the variable capacitor C formed thereby in a circuit including a resistor R and an inductor L. A suitable telemetry device 28 includes an electrically powered external coil or inductor in a circuit with another resistor which can be used for inductively coupling each of the pressure sensors with the telemetry device 28 for detecting pressure sensed by the pressure sensor. In this way, the endograft and its integrated pressure sensors S1 -3 may be implanted inside the patient, with the pressure being detected externally of the patient by the remote telemetry device 28 located outside the skin 12. After initial implantation of the endograft, no orifices through the skin or additional surgery is required for monitoring pressure in the pressure sensing endograft. The endograft 1 8 is used in a system for monitoring pressures related to the performance of the implanted endograft itself, and for monitoring arterial pressure in the blood vessel. In the aneurysm sac pressure embodiment, one or more pressure sensors S1 are embedded in the endograft 18 so that endograft material totally surrounds the sensors, with their pressure-sensing surfaces facing outward toward the aneurysm sac. In a vascular pressure embodiment, one or more pressure sensors S2 are
embedded in the endograft 18 so that endograft material totally surrounds the sensors, with their pressure-sensing surfaces facing inward toward the inside of the lumen to measure the patient's blood pressure. In a hoop stress embodiment, one or more pressure sensors S3 are embedded near the ends of the endograft 18 so that endograft material totally surrounds the sensors, with their pressure-sensing surfaces facing outward toward the aortic wall. These sensors sense the clamping pressure caused by hoop stresses in the aortic wall that push the aortic wall against the sealing surface of the endograft under the action of the patient's blood pressure. In a method embodiment, the signals generated by the sensors S1 , S2, and S3 may be monitored, combined, and processed to provide pressure information to assist in the surgical installation of the endograft and also in monitoring the long-term performance of the endograft. In any of the above embodiments, the electromagnetic energy can be wirelessly passed through the wall of the artery to supply power to the pressure sensors, and return signals from the pressure sensors may be remotely detected. One advantage of the pressure-sensing endograft is that blood pressure within an aneurysm sac and the endograft lumen can be directly monitored. A further advantage of the endograft is that the number of costly CT scans for patients with endovascular grafts can be reduced. A further advantage of the endograft is that the blood pressure within an the aneurysm sac and within the endograft lumen can be periodically monitored using pressure differential trends for a more timely diagnosis of endoleakage. A further advantage of the endograft is that the clamping pressure between the endograft and aorta can be monitored during the insertion procedure to determine when a secure fit has been achieved. A further advantage of the endograft is that the frequency content and pulsatility of the dynamic pressure signals from the sensors measuring aneurysm sac pressure can be compared with the endograft luminal pressure to provide further indication of the performance of the endograft. Yet a further advantage of the endograft is that the clamping pressure between the endograft and aorta can be monitored after the implantation procedure to monitor the integrity of the fit. Yet a further advantage is that these pressures can be monitored wirelessly, so that no wires need penetrate the skin or the artery, and the associated complications of infection and thrombus generation can be avoided.
The pressure sensors S1 through S3 illustrated in figure 1 are preferably embedded inside the endograft material, e.g. woven or knitted synthetic fiber such as Dacron, so that endograft material totally surrounds the sensor beneath a flattened portion to form a flat pressure-sensing surface. The endograft material smoothly blends back to the otherwise curved portion of the endograft. These implanted pressure sensors measure absolute pressures. For clinical relevance, an external barometric reference sensor 30 in the monitoring system converts these pressures to gauge values. As illustrated in Figures 1 and 3, the first and second pressure sensors S1 and S2 are preferably located centrally in the middle of the endograft generally equally between the opposite ends of the sleeve. The flat diaphragm 26 of the first pressure sensor S1 faces radially outwardly and contacts the outer sleeve layer 22 as illustrated in Figure 3 for sensing external pressure Ps outside the endograft sleeve and within the aneurysm sac 16. The first pressure sensor S1 is therefore oriented for measuring pressure in the aneurysm sac 1 6. Multiple sensors S1 may be used for redundancy. The pressure-sensing surface 26 of sensor S1 faces outwardly toward the aneurysm sac. The pressure inside the aneurysm sac is communicated to the pressure sensor through the flattened endograft wall. Correspondingly, the second pressure sensor S2 illustrated in Figures 1 and 3 has its flat diaphragm 26 facing radially inward and contacts the inner layer 20 of the endograft sleeve for sensing internal pressure Pa inside the endograft. The second pressure sensor S2 is preferably located centrally between the opposite ends of the endograft in the same plane as the first pressure sensor S1 , but may be located at any axial location along the endograft where it measures the internal pressure of the flood flow therein. The second pressure sensor S2 is therefore oriented for measuring pressure inside the endograft, which corresponds to the local vascular pressure within the lumen of the endograft. Multiple sensors S2 may be used for redundancy and to detect high flow resistances in the endograft. The pressure-sensing surface 26 of sensor S2 faces inwardly toward the interior of the endograft. The outer layer 22 of endograft material pushes the pressure sensor inward sufficiently to flatten the inner layer 20 of the endograft material against the pressure-sensing surface. The pressure inside the endograft is communicated to the pressure sensor through this flattened endograft wall. Illustrated in Figures 1 , 4, and 5 are the third pressure sensors S3 preferably
disposed in at least a single pair respectively located adjacent opposite ends of the endograft sleeve. Preferably, each end of the endograft includes three equiangularly spaced apart third pressure sensors S3 at a 120° spacing. The end sensors S3 face radially outwardly as illustrated in Figures 4, 5, and 6 to measure contact or clamping pressure Pc exerted against the endograft after it is expanded against the inner wall of the vessel 10. The third pressure sensors S3 are therefore provided for measuring the clamping pressure between the endograft and the aortic wall. The sensors S3 are outward facing and positioned adjacent to each end of the endograft where the endograft engages with the aortic wall. Multiple sensors S3 are preferably used at each end for redundancy, and to detect circumferential variations in the clamping pressure. An endograft that is properly engaged with an aortic wall will expand the aortic wall elastically. A circumferential hoop stress will be established in the aortic wall that will tend to cause an even clamping pressure to be detected by the sensors S3. Without gross non-uniformities in the aortic wall, this even distribution of the force through the hoop stress enables a single or small number of S3 pressure measurements to indicate the existence of good clamping pressure and a good seal around the entire circumferential sealing surface. In contrast, an endograft that is not properly engaged with the aortic wall will not establish such a hoop stress and will cause a lower or nonexistent clamping pressure to be detected by the third sensors S3. This lower clamping pressure can be detected even if there is physical contact between the endograft and aorta. Thus the pressure sensors provide early warning of marginal clamping pressure and imminent leakage before a gross failure associated with loss of contact becomes visible through CT scans. In the preferred embodiment illustrated in Figure 1 the endograft includes all three types of pressure sensors S1 , S2, and S3. The first pressure sensor S1 has its diaphragm 26 facing outwardly for detecting pressure Ps in the aneurysm sac 16. The second pressure sensor S2 has its diaphragm facing radially inwardly for detecting pressure Pa inside the endograft lumen. And, the third pressure sensors S3 are arranged in groups of three at opposite ends of the endograft with their diaphragms 26 facing radially outwardly for detecting the clamping pressure Pc. For cardiovascular applications, it is important that the pressure sensor be securely fixed to its mounting to prevent undesirable liberation. Figure 2 shows the pressure sensor mounted integral within layers of endograft material. The layers of endograft material surround the pressure sensor to prevent detachment. The endograft material is typically a woven fabric. The weave of the endograft
material should be sufficiently fine that the pores are substantially smaller than the pressure sensor notwithstanding any stretching or flexing of the endograft. This configuration minimizes the possibility of the sensor passing through a pore or otherwise becoming detached from the endograft. The implanted endograft material produces a smooth, biocompatible tissue-incorporation that becomes an integral part of the sensor diaphragm. The pressure sensor diaphragm, such as silicon, is made to be stiffer than any tissue that may build up on its surface. Any thickening caused by further tissue buildup has a relatively small effect on the total sensor diaphragm stiffness and sensitivity. In the preferred embodiment illustrated in Figure 1 , the endograft also includes an expandable stent 32 disposed coaxially with the two- ply sleeve thereof for structurally supporting the endograft when implanted in the blood vessel. The stent preferably surrounds the endograft sleeve and may be sewn to the fabric thereof. The inside of the endograft sleeve remains smooth for maintaining a substantially smooth continuous flowpath for the blood flowing therethrough during operation. The stent generally has a single layer of expandable meshwork that undergoes plastic deformation to expand to form a rigid scaffolding to hold open the endograft in an artery. The stent is typically made of a biocompatible metal, such as Nitinol, stainless steel, or titanium. Illustrated in Figures 7 and 8 is the stent 32 of the endograft illustrated in Figure 1 removed therefrom which may include another or fourth pressure sensor S4 fixedly joined to the stent. The stent includes a mesh or grid of interconnected wires 34, and the stent pressure sensor S4 is locally joined to at least one of the wires for retention thereto. The diaphragm 26 of the fourth pressure sensor S4 may face outwardly or inwardly as desired. In the exemplary embodiment illustrated in Figure 8, a plurality of the mesh wires 34 are cut and bent to mechanically trap the pressure sensor to the adjoining mesh wires. The bent mesh wires preferably trap the perimeter of the pressure sensor without covering the diaphragm 26 or preventing pressure sensing operation thereof. Since the pressure sensor is supported by the cut mesh wires, it is freely carried along with the underlying uncut wires as the stent mesh is expanded in use to increase the cylindrical diameter of the tubular stent from its initially small- diameter collapsed form. The stent may therefore freely expand without local distortion around the retained pressure sensor. Figure 9 illustrates an alternate embodiment of the stent 32 in which the mesh wires 34 are not cut but define suitably sized openings or cells between the wires in
which the pressure sensor may be mounted. In this configuration, a perforate frame or box 36 is fixedly joined to one or more of the mesh wires by a weld joint 38. The box may have six sides and a closure flap which is initially open for permitting the pressure sensor S4 to be inserted therein during assembly. The flap may then be simply bent closed for retaining the pressure sensor in the box. The box preferably has two large windows on opposite sides thereof for permitting unobstructed access of the blood to the sensing diaphragm 26. Since the box is secured in one of the mesh cells, the stent may be readily expanded during implantation without restraint by the mounting box itself. The endograft illustrated in the preferred embodiment in Figure 1 incorporates integral pressure sensing capability which may be used to advantage during its initial implantation in the patient as well as for subsequent monitoring of endograft performance thereafter. For example, the endograft may be used for detecting leakage around the endograft after its implantation. As illustrated in Figure 1 , the implanted endograft bridges the aneurysm sac 16, with opposite ends of the endograft contacting inner surfaces of the aorta 10 at opposite ends of the aneurysm to provide effective seals thereat and channel blood through the endograft instead of the aneurysm. The first pressure sensor S1 may then be used to detect external pressure outside the implanted endograft and inside the aneurysm sac for detecting pressure of any blood leakage therein. The second pressure sensor S2 may be correspondingly used to detect internal pressure inside the endograft due to the pressure of the blood 14 channeled therethrough. By simply comparing the external and internal pressures detected by the first and second pressure sensors, an indication of endoleakage may be derived. The external pressure of the endograft should be substantially lower than the internal pressure for normal, sealed operation of the opposite endograft ends. Figure 6 illustrates an exemplary method of using or implanting the endograft 18. The endograft 18 in initially collapsed form is mounted around a conventional balloon catheter 40 and conventionally guided through a suitable artery to a desired position inside the aorta 14 to internally bridge the aneurysm sac 16. The balloon catheter may then be expanded for in turn expanding the endograft and its supporting stent into engagement with the inner surface of the aorta. The two groups of third pressure sensors S3 may then be used for monitoring the clamping pressure of engagement of the endograft with the aorta wall at opposite ends of the endograft sleeve. Endograft expansion by the balloon catheter may be terminated
upon reaching a suitable value of monitored clamping pressure as detected by the third pressure sensors. Because the sensors are embedded in the endograft, separate surgical procedures for implantation thereof are not necessary. Furthermore, because the embedded pressure sensors are read by telemetry, no separate surgical procedure is required for monitoring the pressures needed to diagnose the pressure integrity of the endograft. Thus, follow-up diagnostics for pressure integrity using these sensors are a non-invasive procedure. The patient's blood pressure may vary considerably from moment to moment. These pressure variations may or may not be related to the integrity of the endograft or any leakage of blood into the abdomen. These blood pressure variations may result in artifacts generated in the pressure of the aneurysm sac. Thus, to reduce these artifacts, the differential pressures between the endograft luminal pressure and the aneurysm sac pressure may be monitored. Additionally, these pressure differences may be further analyzed in terms of mean pressure, pulse pressure, and frequency content. The following example illustrates one possible analysis approach for processing the pressure sensor signals: Pa = aortic pressure in the endograft lumen 18 Ma = mean pressure in the endograft lumen Ppa = pulsatile pressure in the endograft lumen Pa = Ma + Ppa Ps = pressure in the aneurysm sac Ms = mean pressure in the aneurysm sac Pps = pulsatile pressure in the aneurysm sac Ps = Ms + Pps
A schematic representation of these parameters as a function of time (t) is illustrated in Figure 10. The monitored pressure differences are shown below: Pulsatile difference = Ppa - Pps Mean difference = Ma - Ms For example, at the time of the endograft insertion, the mean difference may be zero, but there can be an immediate and significant pulsatile difference as soon as the aneurysm is isolated. Over time, the mean difference should increase as the blood in the aneurysm sac transforms into a shrunken thrombus. These distinctions in mean
difference and pulsatile difference may further help eliminate other artifacts. For example, abdominal intestinal bloat that may decrease the mean difference but not significantly change the pulsatile difference. If an endoleak is present, the amount of endoleak can be inferred from the following approach. An analysis of the attenuation of the frequency content of pressure signals reported by S1 and S2 can be an indicator of the impedance of the leak path and the degree to which a high resistance, tight seal has been achieved. This impedance can be analyzed using techniques well known in the art of circuit design. In the equivalent circuit of Figure 1 , a resistor-capacitor circuit models the performance of the pressure sensing system. In Figure 1 1 : R = the resistance to flow from the artery to the aneurysm sac, in mmHg/(mL/second) C = the capacity of the aneurysm sac, in mL/mmHg Pps = the pulsatile pressure in the aneurysm sac reported by sensor S1 , and corresponds to the voltage V1 in an equivalent electrical circuit Ppa = the pulsatile pressure in the artery reported by sensor S2, and corresponds to the voltage V2 in an equivalent electrical circuit Flow = (Ppa - Pps)/R, the flow into the sac in mL/second, and corresponds to current flow in the equivalent electrical circuit T = R x C, the characteristic fill time of the sac, in seconds, and corresponds to the characteristic saturation time of the equivalent electrical circuit. Where the period of the frequency component is small compared to the characteristic time T, i.e., a high frequency component, a small fraction of the pulsatile arterial pressure Ppa is transmitted to the aneurysm sac as Pps. Where the period of the frequency component is large compared to the characteristic time T, i.e., a low frequency component, most of pulsatile arterial pressure Ppa is transmitted to the aneurysm sac as Pps. The cutoff frequency of this low-pass filter (1 /RC) can be used to infer the value of the resistance R with respect to the capacity C. In the field of electrical circuits and signal processing, the characteristic time constant of an RC-circuit is approximately t = R*C (in seconds) and the characteristic cutoff frequency is approximately f = 1 /R*C (in Hz). In the flow analogue to the electrical circuit, R becomes the resistance to flow, in the form of Pressure/Flow through the leak, in units of mmHg/(cc/sec). The capacitance C becomes the compliance of the aneurysm sac, in units of cc/mmHg. The time constant t = RC retains the units of seconds, and frequency f = 1 /RC retains the units
of Hz. Monitoring this cutoff frequency f for changes enables the physician to also monitor changes in the product RC, an indication of leakage rate. If an approximation is used for the compliance C of the aneurysm sac, the leakage resistance R can be directly calculated as R = 1 /fC. The capacitance C is related to the size of the aneurysm sac, which can be seen through radiological images. A typical compliance for an expanded aneurysm sac can be in the range of 1 cc/mmHg. For a cutoff frequency of 5 Hz, the leakage resistance can be approximated by R = 1 /(5 * Hz * 1 * cc/mmHg) = 0.2 mmHg/(cc/sec). These calculations are very approximate and the changes in values should be followed rather than the absolute values. As illustrated in Figure 10, in a preferred method of using the implanted endograft, the mean components of the external pressure Ps(t) and internal pressure Pa(t) may be compared, in a suitable signal processor for example, for detecting endoleakage. Furthermore, a conventional frequency analyzer may be used to uncover the frequency spectra of the pulsatile components of the external and internal pressures as distinct from the mean components thereof for detecting endoleakage. For example, attenuation of the pulsatile components and cutoff frequency therefrom may be determined for detecting the endoleakage in the form of the RC leakage rate described above. Finally, one way to prevent the progression of further aneurysms is to monitor for hypertension, treat the hypertension with appropriate drugs, and monitor for drug effectiveness and patient compliance. Thus, the ability for the patient ambulatory monitoring of his/her blood pressure may be a valuable clinical tool. The pressure sensing endograft described above integrates minute pressure sensors therein for improving both performance of the initial implantation thereof, as well as monitoring use of the endograft over time. Telemetry reading of embedded pressure sensors eliminates need for any surgical procedures in monitoring endograft performance. And, continual monitoring of endograft performance ensures its effectiveness in preventing leakage into the aneurysm. While there have been described herein what are considered to be preferred and exemplary embodiments of the present invention, other modifications of the invention shall be apparent to those skilled in the art from the teachings herein, and it is, therefore, desired to be secured in the appended claims all such modifications as fall within the true spirit and scope of the invention.
Claims
1 . An endograft comprising: a tubular sleeve having integral inner and outer layers; a pressure sensor embedded between said layers and covered thereby; and said sleeve being flexible at said pressure sensor to permit transfer of pressure through said sleeve to said pressure sensor.
2. An endograft according to claim 1 wherein said pressure sensor includes a flat pressure sensing diaphragm, and said sleeve is flexible to conform with said flat diaphragm.
3. An endograft according to claim 2 wherein said diaphragm faces radially outward and contacts said outer layer for sensing pressure external to said sleeve.
4. An endograft according to claim 2 wherein said diaphragm faces radially inward and contacts said inner layer for sensing pressure internal of said sleeve.
5. An endograft according to claim 2 wherein said pressure sensor is located centrally between opposite ends of said sleeve.
6. An endograft according to claim 2 further comprising: a first pressure sensor having said diaphragm thereof facing radially outward and contacting said outer layer for sensing pressure external to said sleeve; and a second pressure sensor having said diaphragm thereof facing radially inward and contacting said inner layer for sensing pressure internal of said sleeve.
7. An endograft according to claim 2 further comprising a pair of said pressure sensors located adjacent opposite ends of said sleeve.
8. An endograft according to claim 7 further comprising three equiangularly spaced apart pressure sensors located adjacent each of said sleeve opposite ends and facing radially outwardly.
9. An endograft according to claim 2 further comprising: a first pressure sensor having said diaphragm thereof facing radially outward and contacting said outer layer for sensing pressure external to said sleeve; a second pressure sensor having said diaphragm thereof facing radially inward and contacting said inner layer for sensing pressure internal of said sleeve; and two pairs of three third pressure sensors equiangularly spaced apart adjacent opposite ends of said sleeve and facing radially outwardly.
10. An endograft according to claim 2 wherein said sleeve layers are fabric.
1 1 . An endograft according to claim 2 wherein said inner and outer layers are coextensive between opposite ends of said sleeve.
12. An endograft according to claim 2 wherein said pressure sensor further includes an inductor for telemetric detection of pressure sensed thereby.
13. An endograft according to claim 2 further comprising a stent disposed coaxially with said sleeve for support thereof.
14. An endograft according to claim 13 further comprising another pressure sensor fixedly joined to said stent.
15. An endograft according to claim 14 wherein said stent includes a mesh of interconnected wires, and said stent pressure sensor is locally joined to at least one of said wires.
16. An endograft according to claim 15 wherein a plurality of said wires are cut and bent to trap said stent pressure sensor to uncut ones of said wires.
17. An endograft according to claim 1 5 further comprising a perforate box fixedly joined to said one stent wire, and said stent pressure sensor is trapped inside said box.
18. A method for using said endograft according to claim 6 to detect leakage therearound comprising: implanting said endograft inside a body vessel having an aneurysm sac, with opposite ends of said endograft contacting inner surfaces of said vessel at opposite ends of said sac; using said first pressure sensor to detect external pressure outside said endograft and inside said sac; using said second pressure sensor to detect internal pressure inside said endograft; and comparing said external and internal pressures to detect leakage.
19. A method according to claim 18 further comprising comparing mean components of said external and internal pressures to detect said leakage.
20. A method according to claim 18 further comprising comparing frequency spectra corresponding with pulsatile components of said external and internal pressures to detect said leakage.
21 . A method according to claim 19 further comprising determining attenuation of said pulsatile components and cutoff frequency therefrom to detect said leakage.
22. A method of implanting said endograft according to claim 8 comprising: expanding said endograft using a balloon catheter inside a body vessel to bridge an aneurysm sac therein; monitoring clamping pressure of engagement of said endograft with said vessel using said pressure sensors at opposite ends of said sleeve; and terminating said endograft expansion at a suitable value of monitored clamping pressure.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29601201P | 2001-06-05 | 2001-06-05 | |
US60/296,012 | 2001-06-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2002098296A1 true WO2002098296A1 (en) | 2002-12-12 |
Family
ID=23140209
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/017062 WO2002098296A1 (en) | 2001-06-05 | 2002-05-31 | Pressure sensing endograft |
Country Status (2)
Country | Link |
---|---|
US (1) | US20020183628A1 (en) |
WO (1) | WO2002098296A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1511446A1 (en) * | 2002-06-07 | 2005-03-09 | Endovascular Technologies, Inc. | Endoprosthesis having pressure, temperature, and flow sensors |
EP1742594A2 (en) * | 2004-01-16 | 2007-01-17 | Endovascular Technologies, Inc. | Endovascular graft with pressor and attachment methods |
WO2008029020A2 (en) * | 2006-09-04 | 2008-03-13 | Universite Pierre Et Marie Curie, Paris Vi | Endoprosthesis, and method for producing an endoprosthesis |
EP2046242A2 (en) * | 2006-07-07 | 2009-04-15 | Anthony Nunez | Methods and systems for monitoring an endoprosthetic implant |
DE102008045876A1 (en) * | 2008-09-06 | 2010-03-11 | Robert Prof. Bauernschmitt | Implanted medical device comprises lattice structure, where sensor is arranged in lattice structure, where sensor is pressure sensor which is piezoelectric crystal, and electrical power supply of implanted medical device |
EP2967928A4 (en) * | 2013-03-14 | 2016-08-31 | Univ Utah Res Found | Stent with embedded pressure sensors |
WO2019121700A1 (en) * | 2017-12-22 | 2019-06-27 | Life Science Inkubator Betriebs Gmbh & Co. Kg | Passive transponder system and pressure wave measuring device |
US10869748B2 (en) | 2016-05-03 | 2020-12-22 | Regents Of The University Of Minnesota | Active monitoring pressure sensitive vascular graft |
US11969230B2 (en) | 2017-12-22 | 2024-04-30 | Vesselsens Gmbh | Passive transponder system and pressure wave measuring device |
Families Citing this family (124)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPO902797A0 (en) | 1997-09-05 | 1997-10-02 | Cortronix Pty Ltd | A rotary blood pump with hydrodynamically suspended impeller |
US20030036746A1 (en) | 2001-08-16 | 2003-02-20 | Avi Penner | Devices for intrabody delivery of molecules and systems and methods utilizing same |
AUPP995999A0 (en) | 1999-04-23 | 1999-05-20 | University Of Technology, Sydney | Non-contact estimation and control system |
US7022100B1 (en) | 1999-09-03 | 2006-04-04 | A-Med Systems, Inc. | Guidable intravascular blood pump and related methods |
US7198603B2 (en) * | 2003-04-14 | 2007-04-03 | Remon Medical Technologies, Inc. | Apparatus and methods using acoustic telemetry for intrabody communications |
US8372139B2 (en) * | 2001-02-14 | 2013-02-12 | Advanced Bio Prosthetic Surfaces, Ltd. | In vivo sensor and method of making same |
AUPR514201A0 (en) * | 2001-05-21 | 2001-06-14 | Ventrassist Pty Ltd | Staged implantation of ventricular assist devices |
US7189256B2 (en) * | 2002-05-10 | 2007-03-13 | Scimed Life Systems, Inc. | Endoluminal device and system and method for detecting a change in pressure differential across an endoluminal device |
US7399313B2 (en) * | 2002-06-07 | 2008-07-15 | Brown Peter S | Endovascular graft with separable sensors |
US7261733B1 (en) * | 2002-06-07 | 2007-08-28 | Endovascular Technologies, Inc. | Endovascular graft with sensors design and attachment methods |
US6918873B1 (en) * | 2002-09-19 | 2005-07-19 | Millar Instruments, Inc. | Inverted sensor module |
AU2002951685A0 (en) * | 2002-09-30 | 2002-10-17 | Ventrassist Pty Ltd | Physiological demand responsive control system |
US20040082867A1 (en) * | 2002-10-29 | 2004-04-29 | Pearl Technology Holdings, Llc | Vascular graft with integrated sensor |
AU2003903726A0 (en) * | 2003-07-18 | 2003-07-31 | Ventracor Limited | A device for detecting heart pumping state |
AU2003904032A0 (en) * | 2003-08-04 | 2003-08-14 | Ventracor Limited | Improved Transcutaneous Power and Data Transceiver System |
CA2541979A1 (en) | 2003-10-09 | 2005-04-14 | Ventracor Limited | Magnetic driven impeller with hyrodynamic bearing |
US7416530B2 (en) * | 2003-11-04 | 2008-08-26 | L & P 100 Limited | Medical devices |
US7572228B2 (en) | 2004-01-13 | 2009-08-11 | Remon Medical Technologies Ltd | Devices for fixing a sensor in a lumen |
CA2554595C (en) | 2004-02-03 | 2016-03-29 | Atria Medical Inc. | Device and method for controlling in-vivo pressure |
US8000784B2 (en) | 2004-04-19 | 2011-08-16 | The Invention Science Fund I, Llc | Lumen-traveling device |
US8271093B2 (en) | 2004-09-17 | 2012-09-18 | Cardiac Pacemakers, Inc. | Systems and methods for deriving relative physiologic measurements using a backend computing system |
US20060083642A1 (en) | 2004-10-18 | 2006-04-20 | Cook Martin C | Rotor stability of a rotary pump |
US7813808B1 (en) | 2004-11-24 | 2010-10-12 | Remon Medical Technologies Ltd | Implanted sensor system with optimized operational and sensing parameters |
US10390714B2 (en) | 2005-01-12 | 2019-08-27 | Remon Medical Technologies, Ltd. | Devices for fixing a sensor in a lumen |
WO2006105098A2 (en) * | 2005-03-29 | 2006-10-05 | Martin Roche | Body parameter detecting sensor and method for detecting body parameters |
US11457813B2 (en) | 2005-03-29 | 2022-10-04 | Martin W. Roche | Method for detecting body parameters |
US8152035B2 (en) * | 2005-07-12 | 2012-04-10 | Thoratec Corporation | Restraining device for a percutaneous lead assembly |
WO2007022288A2 (en) * | 2005-08-15 | 2007-02-22 | Brigham Young University | System for monitoring neural shunt function and associated methods |
US7742815B2 (en) | 2005-09-09 | 2010-06-22 | Cardiac Pacemakers, Inc. | Using implanted sensors for feedback control of implanted medical devices |
US20070142923A1 (en) * | 2005-11-04 | 2007-06-21 | Ayre Peter J | Control systems for rotary blood pumps |
US7686768B2 (en) | 2005-11-23 | 2010-03-30 | Vital Sensors Holding Company, Inc. | Implantable pressure monitor |
US7682313B2 (en) * | 2005-11-23 | 2010-03-23 | Vital Sensors Holding Company, Inc. | Implantable pressure monitor |
US20070142696A1 (en) | 2005-12-08 | 2007-06-21 | Ventrassist Pty Ltd | Implantable medical devices |
US20070142727A1 (en) * | 2005-12-15 | 2007-06-21 | Cardiac Pacemakers, Inc. | System and method for analyzing cardiovascular pressure measurements made within a human body |
US7859208B2 (en) * | 2005-12-19 | 2010-12-28 | Thoratec Corporation | Tuning DC brushless motors |
US8060214B2 (en) | 2006-01-05 | 2011-11-15 | Cardiac Pacemakers, Inc. | Implantable medical device with inductive coil configurable for mechanical fixation |
WO2007083288A2 (en) | 2006-01-23 | 2007-07-26 | Atria Medical Inc. | Heart anchor device |
EP1993438A1 (en) * | 2006-03-14 | 2008-11-26 | CardioMems, Inc. | Sensor, delivery system, and method of fixation |
AU2007201127B2 (en) * | 2006-03-23 | 2012-02-09 | Thoratec Corporation | System For Preventing Diastolic Heart Failure |
US7850594B2 (en) | 2006-05-09 | 2010-12-14 | Thoratec Corporation | Pulsatile control system for a rotary blood pump |
US8478437B2 (en) | 2006-06-16 | 2013-07-02 | The Invention Science Fund I, Llc | Methods and systems for making a blood vessel sleeve |
US8551155B2 (en) | 2006-06-16 | 2013-10-08 | The Invention Science Fund I, Llc | Stent customization system and method |
US20090024152A1 (en) * | 2007-07-17 | 2009-01-22 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Custom-fitted blood vessel sleeve |
US8163003B2 (en) | 2006-06-16 | 2012-04-24 | The Invention Science Fund I, Llc | Active blood vessel sleeve methods and systems |
US20080172073A1 (en) * | 2006-06-16 | 2008-07-17 | Searete Llc, A Limited Liability Corporation Of The State Of Delaware | Active blood vessel sleeve |
US7818084B2 (en) * | 2006-06-16 | 2010-10-19 | The Invention Science Fund, I, LLC | Methods and systems for making a blood vessel sleeve |
US8095382B2 (en) * | 2006-06-16 | 2012-01-10 | The Invention Science Fund I, Llc | Methods and systems for specifying a blood vessel sleeve |
US8550344B2 (en) * | 2006-06-16 | 2013-10-08 | The Invention Science Fund I, Llc | Specialty stents with flow control features or the like |
US8147537B2 (en) * | 2006-06-16 | 2012-04-03 | The Invention Science Fund I, Llc | Rapid-prototyped custom-fitted blood vessel sleeve |
ES2312256B1 (en) * | 2006-06-30 | 2009-12-22 | Universidad Complutense De Madrid | MAGNETIC SENSOR DETECTION OF THE DETERIORATION OF CARDIAC PROTESIS AND METHOD OF DETECTION. |
US7908334B2 (en) * | 2006-07-21 | 2011-03-15 | Cardiac Pacemakers, Inc. | System and method for addressing implantable devices |
AU2007275030B2 (en) * | 2006-07-21 | 2010-07-22 | Cardiac Pacemakers, Inc. | Multiple sensor deployment |
US7955268B2 (en) * | 2006-07-21 | 2011-06-07 | Cardiac Pacemakers, Inc. | Multiple sensor deployment |
ES2369203T3 (en) | 2006-09-15 | 2011-11-28 | Cardiac Pacemakers, Inc. | ANCHORAGE FOR AN IMPLANTABLE MEDICAL DEVICE. |
US8676349B2 (en) | 2006-09-15 | 2014-03-18 | Cardiac Pacemakers, Inc. | Mechanism for releasably engaging an implantable medical device for implantation |
US7963905B2 (en) * | 2006-10-11 | 2011-06-21 | Thoratec Corporation | Control system for a blood pump |
US7647831B2 (en) * | 2006-10-20 | 2010-01-19 | Cardiomems, Inc. | Method for measuring pressure inside an anatomical fluid system |
US20080133006A1 (en) * | 2006-10-27 | 2008-06-05 | Ventrassist Pty Ltd | Blood Pump With An Ultrasonic Transducer |
US20080200750A1 (en) * | 2006-11-17 | 2008-08-21 | Natalie James | Polymer encapsulation for medical device |
US20080140180A1 (en) * | 2006-12-07 | 2008-06-12 | Medtronic Vascular, Inc. | Vascular Position Locating Apparatus and Method |
US20080147173A1 (en) * | 2006-12-18 | 2008-06-19 | Medtronic Vascular, Inc. | Prosthesis Deployment Apparatus and Methods |
US20080172119A1 (en) * | 2007-01-12 | 2008-07-17 | Medtronic Vascular, Inc. | Prosthesis Deployment Apparatus and Methods |
US8473030B2 (en) * | 2007-01-12 | 2013-06-25 | Medtronic Vascular, Inc. | Vessel position and configuration imaging apparatus and methods |
US20080188921A1 (en) * | 2007-02-02 | 2008-08-07 | Medtronic Vascular, Inc. | Prosthesis Deployment Apparatus and Methods |
US8204599B2 (en) | 2007-05-02 | 2012-06-19 | Cardiac Pacemakers, Inc. | System for anchoring an implantable sensor in a vessel |
US7634318B2 (en) | 2007-06-14 | 2009-12-15 | Cardiac Pacemakers, Inc. | Multi-element acoustic recharging system |
US8041431B2 (en) | 2008-01-07 | 2011-10-18 | Cardiac Pacemakers, Inc. | System and method for in situ trimming of oscillators in a pair of implantable medical devices |
US8301262B2 (en) * | 2008-02-06 | 2012-10-30 | Cardiac Pacemakers, Inc. | Direct inductive/acoustic converter for implantable medical device |
JP5211177B2 (en) | 2008-02-11 | 2013-06-12 | カーディアック ペースメイカーズ, インコーポレイテッド | Hemodynamic monitoring method for rhythm discrimination in the heart |
WO2009102640A1 (en) | 2008-02-12 | 2009-08-20 | Cardiac Pacemakers, Inc. | Systems and methods for controlling wireless signal transfers between ultrasound-enabled medical devices |
US20090259296A1 (en) * | 2008-04-10 | 2009-10-15 | Medtronic Vascular, Inc. | Gate Cannulation Apparatus and Methods |
US20090259284A1 (en) * | 2008-04-10 | 2009-10-15 | Medtronic Vascular, Inc. | Resonating Stent or Stent Element |
EP2296536A1 (en) | 2008-07-15 | 2011-03-23 | Cardiac Pacemakers, Inc. | Implant assist apparatus for acoustically enabled implantable medical device |
JP2011529722A (en) | 2008-08-14 | 2011-12-15 | カーディアック ペースメイカーズ, インコーポレイテッド | Performance evaluation and adaptation of acoustic communication links |
JP2012504985A (en) * | 2008-10-10 | 2012-03-01 | グット,カルステン,ニルス | Embedding apparatus and embedding method |
JP5465252B2 (en) | 2008-10-10 | 2014-04-09 | カーディアック ペースメイカーズ, インコーポレイテッド | System and method for determining cardiac output using pulmonary artery pressure measurements |
US8632470B2 (en) | 2008-11-19 | 2014-01-21 | Cardiac Pacemakers, Inc. | Assessment of pulmonary vascular resistance via pulmonary artery pressure |
US8694129B2 (en) | 2009-02-13 | 2014-04-08 | Cardiac Pacemakers, Inc. | Deployable sensor platform on the lead system of an implantable device |
US8562507B2 (en) | 2009-02-27 | 2013-10-22 | Thoratec Corporation | Prevention of aortic valve fusion |
US20100222633A1 (en) * | 2009-02-27 | 2010-09-02 | Victor Poirier | Blood pump system with controlled weaning |
US8449444B2 (en) * | 2009-02-27 | 2013-05-28 | Thoratec Corporation | Blood flow meter |
US20100222878A1 (en) * | 2009-02-27 | 2010-09-02 | Thoratec Corporation | Blood pump system with arterial pressure monitoring |
US20100222635A1 (en) * | 2009-02-27 | 2010-09-02 | Thoratec Corporation | Maximizing blood pump flow while avoiding left ventricle collapse |
US20210161637A1 (en) | 2009-05-04 | 2021-06-03 | V-Wave Ltd. | Shunt for redistributing atrial blood volume |
US8905910B2 (en) | 2010-06-22 | 2014-12-09 | Thoratec Corporation | Fluid delivery system and method for monitoring fluid delivery system |
TW201217010A (en) | 2010-06-22 | 2012-05-01 | Thoratec Corp | Apparatus and method for modifying pressure-flow characteristics of a pump |
US20110319728A1 (en) * | 2010-06-29 | 2011-12-29 | Edwards Lifesciences Corporation | Blood parameter sensor and flow control system, method and computer program product |
TW201225997A (en) | 2010-08-20 | 2012-07-01 | Thoratec Corp | Assembly and method for stabilizing a percutaneous cable |
AU2011305250B2 (en) | 2010-09-24 | 2014-10-02 | Thoratec Corporation | Generating artificial pulse |
JP5852122B2 (en) | 2010-09-24 | 2016-02-03 | ソーラテック コーポレイション | Control of circulation assist device |
US20140081154A1 (en) * | 2011-05-17 | 2014-03-20 | Landy Toth | Devices, systems, and methods for assessing implants, organs, transplants, tissues, synthetic constructs, vascular grafts, and the like |
US9314584B1 (en) | 2011-06-27 | 2016-04-19 | Bayer Healthcare Llc | Method and apparatus for fractional flow reserve measurements |
US8577693B2 (en) | 2011-07-13 | 2013-11-05 | The Invention Science Fund I, Llc | Specialty stents with flow control features or the like |
JP6356152B2 (en) * | 2013-01-24 | 2018-07-11 | グラフトウォークス, インコーポレイテッド | Device for measuring flow through a lumen |
US9757591B2 (en) | 2013-02-11 | 2017-09-12 | Bayer Healthcare Llc | Methods and systems for monitoring an automated infusion system |
EP2999412B1 (en) | 2013-05-21 | 2020-05-06 | V-Wave Ltd. | Apparatus for delivering devices for reducing left atrial pressure |
EP3182927A1 (en) * | 2014-08-18 | 2017-06-28 | St. Jude Medical, Cardiology Division, Inc. | Prosthetic heart devices having diagnostic capabilities |
US9808201B2 (en) | 2014-08-18 | 2017-11-07 | St. Jude Medical, Cardiology Division, Inc. | Sensors for prosthetic heart devices |
US9924905B2 (en) | 2015-03-09 | 2018-03-27 | Graftworx, Inc. | Sensor position on a prosthesis for detection of a stenosis |
US9757574B2 (en) | 2015-05-11 | 2017-09-12 | Rainbow Medical Ltd. | Dual chamber transvenous pacemaker |
LU93035B1 (en) * | 2016-04-20 | 2017-10-27 | Technische Univ Hamburg Harburg | Tissue Stent |
US20170340460A1 (en) | 2016-05-31 | 2017-11-30 | V-Wave Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
US10835394B2 (en) | 2016-05-31 | 2020-11-17 | V-Wave, Ltd. | Systems and methods for making encapsulated hourglass shaped stents |
WO2018049412A1 (en) | 2016-09-12 | 2018-03-15 | Graftworx, Inc. | Wearable device with multimodal diagnostics |
US11291807B2 (en) | 2017-03-03 | 2022-04-05 | V-Wave Ltd. | Asymmetric shunt for redistributing atrial blood volume |
US11045128B2 (en) | 2017-06-03 | 2021-06-29 | Sentinel Medical Technologies, LLC | Catheter for monitoring intra-abdominal pressure |
US10813589B2 (en) | 2017-06-03 | 2020-10-27 | Sentinel Medical Technologies, LLC | Catheter for monitoring uterine contraction pressure |
US10799131B2 (en) | 2017-06-03 | 2020-10-13 | Sentinel Medical Technologies, LLC | Catheter for monitoring intrauterine pressure to protect the fallopian tubes |
US11045143B2 (en) | 2017-06-03 | 2021-06-29 | Sentinel Medical Technologies, LLC | Catheter with connectable hub for monitoring pressure |
US11185245B2 (en) | 2017-06-03 | 2021-11-30 | Sentinel Medical Technologies, Llc. | Catheter for monitoring pressure for muscle compartment syndrome |
US10441221B2 (en) * | 2017-06-26 | 2019-10-15 | Cook Medical Technologies Llc | Graft prosthesis with pocket for microsystem |
US11744589B2 (en) | 2018-01-20 | 2023-09-05 | V-Wave Ltd. | Devices and methods for providing passage between heart chambers |
US11458287B2 (en) | 2018-01-20 | 2022-10-04 | V-Wave Ltd. | Devices with dimensions that can be reduced and increased in vivo, and methods of making and using the same |
CN110403738B (en) * | 2018-04-28 | 2023-01-31 | 京东方科技集团股份有限公司 | Aortic stent, implantation method thereof and aneurysm cavity internal pressure monitor |
US11672457B2 (en) | 2018-11-24 | 2023-06-13 | Sentinel Medical Technologies, Llc. | Catheter for monitoring pressure |
US11779263B2 (en) | 2019-02-08 | 2023-10-10 | Sentinel Medical Technologies, Llc. | Catheter for monitoring intra-abdominal pressure for assessing preeclampsia |
WO2020191203A1 (en) | 2019-03-20 | 2020-09-24 | inQB8 Medical Technologies, LLC | Aortic dissection implant |
US11612385B2 (en) | 2019-04-03 | 2023-03-28 | V-Wave Ltd. | Systems and methods for delivering implantable devices across an atrial septum |
CN114096205A (en) | 2019-05-20 | 2022-02-25 | V-波有限责任公司 | System and method for creating room shunt tubes |
US11730385B2 (en) | 2019-08-08 | 2023-08-22 | Sentinel Medical Technologies, LLC | Cable for use with pressure monitoring catheters |
US11617543B2 (en) | 2019-12-30 | 2023-04-04 | Sentinel Medical Technologies, Llc. | Catheter for monitoring pressure |
US11234702B1 (en) * | 2020-11-13 | 2022-02-01 | V-Wave Ltd. | Interatrial shunt having physiologic sensor |
WO2023199267A1 (en) | 2022-04-14 | 2023-10-19 | V-Wave Ltd. | Interatrial shunt with expanded neck region |
CN115517635A (en) * | 2022-09-26 | 2022-12-27 | 天津大学 | Passive implantable blood state monitoring sensor and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5967986A (en) * | 1997-11-25 | 1999-10-19 | Vascusense, Inc. | Endoluminal implant with fluid flow sensing capability |
US6053873A (en) * | 1997-01-03 | 2000-04-25 | Biosense, Inc. | Pressure-sensing stent |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5702419A (en) * | 1994-09-21 | 1997-12-30 | Wake Forest University | Expandable, intraluminal stents |
US6048360A (en) * | 1997-03-18 | 2000-04-11 | Endotex Interventional Systems, Inc. | Methods of making and using coiled sheet graft for single and bifurcated lumens |
US6015387A (en) * | 1997-03-20 | 2000-01-18 | Medivas, Llc | Implantation devices for monitoring and regulating blood flow |
US6409674B1 (en) * | 1998-09-24 | 2002-06-25 | Data Sciences International, Inc. | Implantable sensor with wireless communication |
US6331163B1 (en) * | 1998-01-08 | 2001-12-18 | Microsense Cardiovascular Systems (1196) Ltd. | Protective coating for bodily sensor |
US6206835B1 (en) * | 1999-03-24 | 2001-03-27 | The B. F. Goodrich Company | Remotely interrogated diagnostic implant device with electrically passive sensor |
US6309350B1 (en) * | 1999-05-03 | 2001-10-30 | Tricardia, L.L.C. | Pressure/temperature/monitor device for heart implantation |
US6315733B1 (en) * | 2000-01-14 | 2001-11-13 | Zimmon Science Corp. | Apparatus and method for continuous measurement of portal blood pressure |
US6416474B1 (en) * | 2000-03-10 | 2002-07-09 | Ramon Medical Technologies Ltd. | Systems and methods for deploying a biosensor in conjunction with a prosthesis |
-
2002
- 2002-05-31 US US10/160,741 patent/US20020183628A1/en not_active Abandoned
- 2002-05-31 WO PCT/US2002/017062 patent/WO2002098296A1/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6053873A (en) * | 1997-01-03 | 2000-04-25 | Biosense, Inc. | Pressure-sensing stent |
US5967986A (en) * | 1997-11-25 | 1999-10-19 | Vascusense, Inc. | Endoluminal implant with fluid flow sensing capability |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1511446A4 (en) * | 2002-06-07 | 2009-02-11 | Endovascular Tech Inc | Endoprosthesis having pressure, temperature, and flow sensors |
EP1511446A1 (en) * | 2002-06-07 | 2005-03-09 | Endovascular Technologies, Inc. | Endoprosthesis having pressure, temperature, and flow sensors |
EP1742594A2 (en) * | 2004-01-16 | 2007-01-17 | Endovascular Technologies, Inc. | Endovascular graft with pressor and attachment methods |
JP2007525260A (en) * | 2004-01-16 | 2007-09-06 | エンドバスキュラー テクノロジーズ インコーポレイテッド | Endovascular graft with sensor and attachment method |
EP1742594A4 (en) * | 2004-01-16 | 2008-01-09 | Endovascular Tech Inc | Endovascular graft with pressor and attachment methods |
EP2046242A2 (en) * | 2006-07-07 | 2009-04-15 | Anthony Nunez | Methods and systems for monitoring an endoprosthetic implant |
EP2046242A4 (en) * | 2006-07-07 | 2010-08-25 | Endotronix Inc | Methods and systems for monitoring an endoprosthetic implant |
CN101557777B (en) * | 2006-09-04 | 2012-07-25 | 皮埃尔与玛丽·居里-巴黎第六大学 | Stent, and method for producing an stent |
WO2008029020A2 (en) * | 2006-09-04 | 2008-03-13 | Universite Pierre Et Marie Curie, Paris Vi | Endoprosthesis, and method for producing an endoprosthesis |
WO2008029020A3 (en) * | 2006-09-04 | 2008-05-22 | Univ Paris Curie | Endoprosthesis, and method for producing an endoprosthesis |
US8187317B2 (en) | 2006-09-04 | 2012-05-29 | Universite Pierre Et Marie Curie-Paris Vi | Endoprosthesis, and method for producing an endoprosthesis |
DE102008045876A1 (en) * | 2008-09-06 | 2010-03-11 | Robert Prof. Bauernschmitt | Implanted medical device comprises lattice structure, where sensor is arranged in lattice structure, where sensor is pressure sensor which is piezoelectric crystal, and electrical power supply of implanted medical device |
EP2967928A4 (en) * | 2013-03-14 | 2016-08-31 | Univ Utah Res Found | Stent with embedded pressure sensors |
US9999528B2 (en) | 2013-03-14 | 2018-06-19 | University Of Utah Research Foundation | Stent with embedded pressure sensors |
US10869748B2 (en) | 2016-05-03 | 2020-12-22 | Regents Of The University Of Minnesota | Active monitoring pressure sensitive vascular graft |
WO2019121700A1 (en) * | 2017-12-22 | 2019-06-27 | Life Science Inkubator Betriebs Gmbh & Co. Kg | Passive transponder system and pressure wave measuring device |
US11969230B2 (en) | 2017-12-22 | 2024-04-30 | Vesselsens Gmbh | Passive transponder system and pressure wave measuring device |
Also Published As
Publication number | Publication date |
---|---|
US20020183628A1 (en) | 2002-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20020183628A1 (en) | Pressure sensing endograft | |
EP1511446B1 (en) | Endoprosthesis having pressure, temperature, and flow sensors | |
US7261733B1 (en) | Endovascular graft with sensors design and attachment methods | |
JP4559430B2 (en) | Endovascular graft with separable sensor | |
JP2009542421A (en) | Method and system for monitoring an endoprosthesis implant | |
US6840956B1 (en) | Systems and methods for deploying a biosensor with a stent graft | |
US20050065592A1 (en) | System and method of aneurism monitoring and treatment | |
US6699186B1 (en) | Methods and apparatus for deploying and implantable biosensor | |
US6890303B2 (en) | Implantable device for monitoring aneurysm sac parameters | |
US8187317B2 (en) | Endoprosthesis, and method for producing an endoprosthesis | |
US6743180B1 (en) | Pressure sensor for use in an artery | |
JP2007525260A (en) | Endovascular graft with sensor and attachment method | |
EP1356765B1 (en) | Sensing device and method for determining aneurysmal pressure in a body cavity | |
US20220167922A1 (en) | Providing medical devices with sensing functionality | |
US20160256107A1 (en) | Detection of stenosis in a prosthesis using break frequency | |
WO2002000118A2 (en) | Pressure gradient measurement for detection of shunt stenosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU BR CA CH DE ES GB JP KR MX SE |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |